Daisuke Nonaka

Pseudomyxoma Peritonei: Clinical Pathological and Biological Prognostic Factors in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Dario Baratti, Shigeki Kusamura, Daisuke Nonaka et al. · Annals of Surgical Oncology · 2007 · 182 citations

Cytoreductive Surgery, Surgical Oncology, Surgical Pathology +5

Prognostic Analysis of Clinicopathologic Factors in 49 Patients With Diffuse Malignant Peritoneal Mesothelioma Treated With Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion

Marcello Deraco, Daisuke Nonaka, Dario Baratti et al. · Annals of Surgical Oncology · 2006 · 153 citations

Cytoreductive Surgery, Surgical Oncology, Medicine +6

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients

Lorenzo Pilla, Roberto Patuzzo, Licia Rivoltini et al. · Cancer Immunology Immunotherapy · 2005 · 137 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Phase Ii Trial +13

Pseudomyxoma Peritonei

Dario Baratti, Shigeki Kusamura, Daisuke Nonaka et al. · Annals of Surgery · 2009 · 103 citations

Multicystic and Well-differentiated Papillary Peritoneal Mesothelioma Treated by Surgical Cytoreduction and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)

Dario Baratti, Shigeki Kusamura, Daisuke Nonaka et al. · Annals of Surgical Oncology · 2007 · 55 citations

Surgical Oncology, Medicine, Surgical Pathology +6